{
    "Pharmaceuticals_Q3FY25": [
        {
            "company_name": "Sun Pharmaceutical Industries",
            "market_cap_crore": 418228.08,
            "net_sales": {
                "Q3FY25": 13675.46,
                "Q3FY24": 12380.7,
                "Q2FY25": 13291.39,
                "YoY_Growth": 10.46,
                "QoQ_Growth": 2.89
            },
            "net_profit": {
                "Q3FY25": 2917.54,
                "Q3FY24": 2568.03,
                "Q2FY25": 3030.67,
                "YoY_Growth": 13.61,
                "QoQ_Growth": -3.73
            }
        },
        {
            "company_name": "Cipla",
            "market_cap_crore": 119474.38,
            "net_sales": {
                "Q3FY25": 7072.97,
                "Q3FY24": 6603.81,
                "Q2FY25": 7051.02,
                "YoY_Growth": 7.1,
                "QoQ_Growth": 0.31
            },
            "net_profit": {
                "Q3FY25": 1583.72,
                "Q3FY24": 1068.51,
                "Q2FY25": 1306.02,
                "YoY_Growth": 48.22,
                "QoQ_Growth": 21.26
            }
        },
        {
            "company_name": "Torrent Pharmaceuticals",
            "market_cap_crore": 110306.14,
            "net_sales": {
                "Q3FY25": 2809,
                "Q3FY24": 2732,
                "Q2FY25": 2889,
                "YoY_Growth": 2.82,
                "QoQ_Growth": -2.77
            },
            "net_profit": {
                "Q3FY25": 503,
                "Q3FY24": 443,
                "Q2FY25": 453,
                "YoY_Growth": 13.54,
                "QoQ_Growth": 11.04
            }
        },
        {
            "company_name": "Max Healthcare Institute",
            "market_cap_crore": 103265.79,
            "net_sales": {
                "Q3FY25": 1868.31,
                "Q3FY24": 1334.97,
                "Q2FY25": 1707.46,
                "YoY_Growth": 39.95,
                "QoQ_Growth": 9.42
            },
            "net_profit": {
                "Q3FY25": 238.8,
                "Q3FY24": 289.34,
                "Q2FY25": 281.81,
                "YoY_Growth": -17.47,
                "QoQ_Growth": -15.26
            }
        },
        {
            "company_name": "Dr. Reddy's Laboratories",
            "market_cap_crore": 101599.46,
            "net_sales": {
                "Q3FY25": 8381.2,
                "Q3FY24": 7236.8,
                "Q2FY25": 8038.2,
                "YoY_Growth": 15.81,
                "QoQ_Growth": 4.27
            },
            "net_profit": {
                "Q3FY25": 1400,
                "Q3FY24": 1378.2,
                "Q2FY25": 1335.8,
                "YoY_Growth": 1.58,
                "QoQ_Growth": 4.81
            }
        },
        {
            "company_name": "Mankind Pharma",
            "market_cap_crore": 100540.49,
            "net_sales": {
                "Q3FY25": 3230,
                "Q3FY24": 2606.95,
                "Q2FY25": 3076.51,
                "YoY_Growth": 23.9,
                "QoQ_Growth": 4.99
            },
            "net_profit": {
                "Q3FY25": 381.08,
                "Q3FY24": 455.21,
                "Q2FY25": 656.31,
                "YoY_Growth": -16.28,
                "QoQ_Growth": -41.94
            }
        },
        {
            "company_name": "Biocon",
            "market_cap_crore": 43527.75,
            "net_sales": {
                "Q3FY25": 3821.4,
                "Q3FY24": 3953.7,
                "Q2FY25": 3590.4,
                "YoY_Growth": -3.35,
                "QoQ_Growth": 6.43
            },
            "net_profit": {
                "Q3FY25": 81.1,
                "Q3FY24": 777.4,
                "Q2FY25": 27.1,
                "YoY_Growth": -89.57,
                "QoQ_Growth": 199.26
            }
        },
        {
            "company_name": "Ajanta Pharma",
            "market_cap_crore": 33706.28,
            "net_sales": {
                "Q3FY25": 1146.13,
                "Q3FY24": 1105.15,
                "Q2FY25": 1186.64,
                "YoY_Growth": 3.71,
                "QoQ_Growth": -3.41
            },
            "net_profit": {
                "Q3FY25": 232.88,
                "Q3FY24": 210.03,
                "Q2FY25": 216.48,
                "YoY_Growth": 10.88,
                "QoQ_Growth": 7.58
            }
        },
        {
            "company_name": "Laurus Labs",
            "market_cap_crore": 31484.26,
            "net_sales": {
                "Q3FY25": 1415.05,
                "Q3FY24": 1194.92,
                "Q2FY25": 1223.7,
                "YoY_Growth": 18.42,
                "QoQ_Growth": 15.64
            },
            "net_profit": {
                "Q3FY25": 90.61,
                "Q3FY24": 25.17,
                "Q2FY25": 17.72,
                "YoY_Growth": 259.99,
                "QoQ_Growth": 411.34
            }
        },
        {
            "company_name": "Piramal Pharma",
            "market_cap_crore": 30876.67,
            "net_sales": {
                "Q3FY25": 2204.22,
                "Q3FY24": 1958.57,
                "Q2FY25": 2241.75,
                "YoY_Growth": 12.54,
                "QoQ_Growth": -1.67
            },
            "net_profit": {
                "Q3FY25": -13.37,
                "Q3FY24": -3.84,
                "Q2FY25": 5.33,
                "YoY_Growth": -248.18,
                "QoQ_Growth": -350.84
            }
        }
    ]
}